<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55394947/asymchems-carbapenem-api-facility-passes-first-fda-pre-approval-inspection</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-31T16:43:05.000Z</news:publication_date><news:title>Asymchem’s carbapenem API facility passes FDA pre-approval inspection</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55394945/hilleman-laboratories-secures-up-to-85m-for-ebola-vaccine-manufacturing</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-31T16:42:25.000Z</news:publication_date><news:title>Hilleman Laboratories secures up to $8.5M for Ebola vaccine manufacturing</news:title></news:news></url></urlset>